InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,632.69
(
0.90%
)
Post# of 253281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rogerm

Send PM Follow Ignore
Followers 2
Posts 112
Boards Moderated 0
Alias Born 08/04/2005

rogerm

Re: biotech jim post# 181273

Sunday, 08/17/2014 2:06:17 PM

Sunday, August 17, 2014 2:06:17 PM

Post# of 253281
Curious if you have discussed Pimavanserin with Hargreaves. ACAD is about to start it in a P2 PD sleep trial. Doubt we ever see it in a P3 because a successful P2 may be enough to capture AD/PD sleep rxs away from patients currently using off label low dose Desyrel and Seroquel. What do you think?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up